Langenfeld, Germany, June 03, 2026 (GLOBE NEWSWIRE) -- Booking Health today announced the release of findings examining international patient access to personalized dendritic cell therapy for glioblastoma in Germany. The findings, based on a documented Canadian patient case and supporting clinical research, highlight how cross-border treatment pathways may provide patients with aggressive brain tumors access to individualized immunotherapy options that are not widely available within all healthcare systems.
New GeneSight ® Mental Health Monitor Reveals 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan
New GeneSight ® Mental Health Monitor Reveals 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan
TAIPEI , June 3, 2026 /PRNewswire/ -- NVIDIA GTC -- GMI Cloud, an AI-native cloud infrastructure company purpose-built for production AI, today announced its support for...
VALENCIA, Calif., June 3, 2026 /PRNewswire/ -- Sunkist Growers unveiled a refreshed Sunkist.com experience, introducing a bold new digital platform built around a simple...
Purpose-built for law enforcement, legal, government, healthcare, and financial services, VIDIZMO AI Intelligence Hub analyzes video, audio, documents, and images together, on your private...
New capital supports growth of platform connecting landowners and hunters nationwideMINNEAPOLIS, June 3, 2026 /PRNewswire/ -- HLRBO, a marketplace connecting landowners with hunters seeking private-land...
NEW YORK, June 3, 2026 /PRNewswire/ -- Consumer365 has published a new review examining why Quay is gaining visibility among shoppers searching for viral...